1,236 results on '"Fiorentino, Michelangelo"'
Search Results
102. Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis
103. Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions
104. The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer
105. Site-specific concordance of targeted and systematic biopsy cores at the index lesion on multiparametric magnetic resonance: can we spare the double-tap?
106. Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers
107. ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC
108. A case report of myoid gonadal stromal tumor treated with testis sparing surgery
109. Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer
110. Oestrogen and progesterone receptors in melanoma and nevi: an immunohistochemical study
111. Revised Gleason Grading System Is a Better Predictor of Indolent Prostate Cancer at the Time of Diagnosis: Retrospective Clinical-Pathological Study on Matched Biopsy and Radical Prostatectomy Specimens
112. Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions
113. Influence of neighborhood social and natural environment on prostatic tumor histology in a US-based cohort of male health professionals
114. SOX2 and PRAME in the “reprogramming” of seminoma cells
115. A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy.
116. AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
117. Influence of K-ras status and anti-tumour treatments on complications due to colorectal self-expandable metallic stents: A retrospective multicentre study
118. Fading With Time of PD-L1 Immunoreactivity in Non–Small Cells Lung Cancer Tissues: A Methodological Study
119. Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma
120. Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins
121. FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer
122. ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation
123. Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge.
124. Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1 / BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer.
125. Differing Risk of Cancer Death Among Patients With Pathologic T3a Renal Cell Carcinoma: Identification of Risk Categories According to Fat Infiltration and Renal Vein Thrombosis
126. Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells
127. Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review
128. BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases
129. Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?
130. Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters
131. Interobserver agreement of PD-L1 (SP263) assessment in advanced NSCLC on cytological smears and histological samples
132. The EORTC protocol for sentinel lymph node biopsy (SLNB) reveals a high number of nodal nevi and a strong association with nevus-associated melanoma
133. Hematoxylin and eosin or double stain for CD34/SOX10: Which is better for the detection of lymphovascular invasion in cutaneous melanoma?
134. The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: A retrospective study
135. CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer
136. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
137. Additional file 1 of Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer
138. Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters.
139. Chapter 2 - Overview of liquid biopsy
140. The role of MRI in the detection of local recurrence: Added value of multiparametric approach and Signal Intensity/Time Curve analysis
141. Intra‐epithelial non‐canonical Activin A signaling safeguards prostate progenitor quiescence
142. PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists
143. Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade
144. The Pathology and Molecular Pathology of Hepatocellular Carcinoma
145. Epidemiology of Hepatocellular Carcinoma
146. Nanotechnology-Related Environment, Health, and Safety Research
147. The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy
148. Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays
149. Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care
150. Author response: Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.